Metrics as of 10/14/2026, 02:17 PM (Berlin time), refresh in progress.
InMode Stock
InMode Ltd.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- Israel
- CEO
- Moshe Mizrahy
- Employees
- 660
- Market cap
- $822 M
- IPO
- 08/08/2019
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings,…
InMode stock: price history
1D
+0.1%
1W
+2.3%
1M
-4.0%
6M
+1.2%
YTD
-2.6%
1Y
-6.5%
2Y
-13.3%
5Y
-79.7%
10Y
–
Next earnings date
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~1% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 12/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about InMode
Analyst assessment of InMode
PRICE TARGET LOW
US$19.00
CONSENSUS
US$19.00
MEDIAN
US$19.00
PRICE TARGET HIGH
US$19.00
0
STRONG BUY
5
BUY
6
HOLD
0
SELL
0
STRONG SELL
11
TOTAL · Hold
As of: 07/05/2026
InMode stock metrics
P/E
11.44
P/B
1.34
EV/EBITDA
5.11
RETURN ON EQUITY
2.7%
NET MARGIN
17.9%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
83.7%
FLOAT SHARES
48,090,679
AVG. DAILY VOLUME (30D)
492,564
Insider transactions (SEC)
Itzkovich Moshe
Ron Hadar
Nass Shlomo
Kenneth Nadav
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about InMode stock
What does InMode do?
InMode Ltd. is a company in the Healthcare sector, Medical - Devices industry, headquartered in Israel.
The CEO is Moshe Mizrahy, the company employs around 660 people.
The IPO was on 08/08/2019; the stock trades on NASDAQ under the ticker INMD.
What do analysts say about InMode stock?
11 analysts rate the stock, the consensus is Hold (as of 07/05/2026).
The average price target is US$19.00, ranging from US$19.00 to US$19.00, with a median of US$19.00.
This is an external assessment, not a statement by Market Jury.
When does InMode report next?
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 1% stronger than usual.
Does InMode pay a dividend?
No, InMode currently does not pay a dividend.
Which stocks are comparable to InMode?
Comparable stocks include Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, Siemens Healthineers, DexCom and GE HealthCare Technologies.
How can I get InMode stock analyzed?
Clicking "Analyze stock" lets five strategies assess InMode against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.